[Clinical diagnosis and treatment of optic nerve glioma: a review].

Optic nerve glioma (ONG) is a relatively rare central nervous system tumor that mainly affects children and adolescents. It can be classified into sporadic and neurofibromatosis type 1 (NF1)-associated types. The histological type is mainly a low-grade pilocytic astrocytoma. The typical clinical manifestations are visual impairment and painless eye protrusion, and the imaging features mainly present as fusiform swelling or irregular masses. Chemotherapy is still the first-line treatment for ONG, and other treatment options include radiotherapy, surgical resection, and molecular targeted therapy. Screening and monitoring of NF1 patients are also crucial. The prognosis of ONG is difficult to predict, and close monitoring and timely effective intervention are necessary.

Investigation of the shape change of bio-flocs and its influence on mass transport using particle image velocimetry.

In this laboratory study, an advanced flow visualization technique - particle image velocimetry (PIV) - was employed to investigate the change of shape of activated sludge flocs in water and its influence on the material transport characteristics of the flocs. The continuous shape change of the bio-flocs that occurred within a very short period of time could be captured by the PIV system. The results demonstrate that the fluid turbulence caused the shift of parts of a floc from one side to the other in less than 200 ms. During the continuous shape change, the liquid within the floc was forced out of the floc, which was then refilled with the liquid from the surrounding flow. For the bio-flocs saturated with a tracer dye, it was shown that the dye could be released from the flocs at a faster rate when the flocs were swayed around in water. The experimental results indicate that frequent shape change of bio-flocs facilitates the exchange of fluid and materials between the floc interior and the surrounding water. This mass transfer mechanism can be more important than molecular diffusion and internal permeation to the function and behavior of particle aggregates, including bio-flocs, in natural waters and treatment systems.

Effect of glucocorticoid therapy on the prognosis of patients with severe and critical COVID-19: a single-center retrospective cohort study.

OBJECTIVE: Coronavirus disease 2019 (COVID-19) has elevated mortality in severe and critical patients globally. This study examined the effect of glucocorticoids (GCS) on the time of virus clearance and absorption of lung lesions in severe and critical COVID-19 patients. PATIENTS AND METHODS: Severe and critical COVID-19 cases diagnosed in Wuhan Pulmonary Hospital from January 7 to February 10, 2020 were analyzed. The generalized linear model was utilized to assess the effects of GCS therapy on the times of nucleic acid test turning negative and improved pulmonary imaging, respectively. RESULTS: Of 66 patients, 51 (77.3%) and 15 (22.7%) were severe and critical cases, respectively, and aged 62 ± 11 years. A total of 58 patients (87.9%) tested negative, and 56 (84.8%) showed improved lung imaging. Age, thrombocytopenia, CD8 + T cell count, course of GCS therapy, and total dose were correlated with the time of nucleic acid test turning negative (p < 0.05), and sex was correlated with the time of initial pulmonary imaging improvement (p < 0.05). The time of nucleic acid test turning negative in individuals with GCS therapy course ≤ 10 days was shorter than that of the GCS therapy course > 10 days group (p=0.001). No statistical difference was found in the dose, course of GCS, and initial time of improved lung imaging. CONCLUSIONS: Increasing the dose of GCS and prolonging the course of treatment do not shorten the time of nucleic acid test turning negative or improved absorption of pulmonary lesions. Thus, the rational use of GCS is particularly important.